ANATOMY OF A FAILURE TO LAUNCH: BARRIERS TO GENERIC MARKET ENTRY AND THE USE OF COMPETITION LAW AS A REMEDY
Section
Health & Consumers
Event Description
The webinar will be the occasion for the launch of a White Paper entitled “Anatomy of a failure to launch: A review of barriers to generic and biosimilar entry and the use of competition law”.
The discussion will focus on how to make sure that current barriers to generic and biosimilar medicines market entry can be tackled in order to avoid any unnecessary delays to patient access.
The launch of the White Paper aims to inform the current debate around the IP strategy in the context of the broader Pharmaceutical Strategy of the European Commission. Discussions will include how to deal with IP and patent quality, patent linkage, pricing strategies, as well as ways to ensure effective competition in the pharmaceutical market.
Events of the week
Jobs
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
Global Heart Hub
European Schoolnet
Freshfel Europe
EBF (the European Banking Federation)
ChargeUp Europe
B'nai B'rith Europe
ENoP - European Network of Political Foundations
EURACTIV News
- Zelenskyy calls for air defense systems as allies meet
- Columbia leadership rebuked by faculty panel for police crackdown on protesters
- Gaza student protest in Paris sees tense standoff with Israel supporters
- Von der Leyen to avoid TikTok in very ‘personal’ campaign
- Bolt lobbying revelations: Estonia official says human error behind missing correspondence